BioVersys AG Revenue and Competitors
Estimated Revenue & Valuation
- BioVersys AG's estimated annual revenue is currently $3.7M per year.
- BioVersys AG's estimated revenue per employee is $104,000
Employee Data
- BioVersys AG has 36 Employees.
- BioVersys AG grew their employee count by 16% last year.
BioVersys AG's People
| Name | Title | Email/Phone |
|---|
BioVersys AG Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.8M | 27 | -4% | $15.7M | N/A |
#2 | $25.5M | 178 | -3% | N/A | N/A |
#3 | $1.4M | 22 | -50% | $21.2M | N/A |
#4 | $56.6M | 348 | 19% | $6M | N/A |
#5 | $6.3M | 56 | -21% | $216.8M | N/A |
#6 | $0M | 2 | 0% | $33.3M | N/A |
#7 | $33.3M | 233 | 0% | N/A | N/A |
#8 | $32.4M | 232 | -26% | $64.6M | N/A |
#9 | $30M | 215 | -22% | $46.8M | N/A |
#10 | $261.6M | 1407 | 15% | $75M | N/A |
What Is BioVersys AG?
Bioversys AG is a privately held Swiss biopharmaceutical company located in Basel that focuses on research and development of new drugs and compounds, which switch-off drug resistance within bacterial pathogens and restore the efficacy of approved antibiotics. Spun out of the ETH-Zurich in 2008, we have profound technological expertise that is based on solid IP.
keywords:N/A
N/A
Total Funding
36
Number of Employees
$3.7M
Revenue (est)
16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioVersys AG News
2022-04-17 - Multidrug Resistant Bacteria Market Provides in-depth ...
Achaogen, Inc, Nabriva Therapeutics plc, BioVersys AG, Johnson & Johnson Services, Inc, Destiny Pharma plc, Armata Pharmaceuticals, Inc,...
Other Companies in Basel
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.5M | 38 | 65% | N/A |
#2 | $10.3M | 40 | -25% | N/A |
#3 | $6.2M | 40 | 38% | N/A |
#4 | $7.8M | 41 | 11% | $210M |
#5 | $6.4M | 41 | 21% | N/A |